osteoporosis%20in%20women
OSTEOPOROSIS IN WOMEN
Osteoporosis is a progressive, systemic, skeletal disease characterized by decreased bone mass and microarchitectural deterioration of bone tissue leading to increased bone fragility and susceptibility to fractures.
The more risk factors (eg history of fracture, advanced age, comorbidities, etc) that are present, the greater the risk of fracture.
Drug Information

Indication: Treatment & prevention of osteoporosis in postmenopausal women. Reduction in risk of invasive breast cance...

Indication: Osteoporosis in postmenopausal women & men at increased risk of fracture. Osteoporosis associated w/ susta...

Indication: Complaints resulting from natural or artificial menopause. Prevention of osteoporosis in postmenopausal women ...

Indication: Diseases caused by disturbances in the Ca metabolism in consequence of reduced endogenous production of 1,25-d...

Indication: Osteoporosis in postmenopausal women at increased risk of fracture. Increases bone mineral density & reduc...

Indication: Health or dietary supplement.

Indication: Established postmenopausal osteoporosis; renal osteodystrophy in patients w/ chronic renal failure particularl...

Sante
ascorbic acid + calcium carbonate + calcium lactat...

Indication: Dietary supplement.

2  /  5
Digital Edition
Asia's trusted medical magazine for healthcare professionals. Get your MIMS JPOG - Malaysia digital copy today!
Sign In To Download
Editor's Recommendations
Most Read Articles
12 Dec 2019
Rotavirus (RV) is highly contagious. Globally, 2 million children are hospitalized and more than 500,000 die annually from RV associated gastroenteritis. Therefore, vaccination is imperative for the prevention of RV infections.